Fundraising Fox

MBX Biosciences

NASDAQ: MBX

Carmel, US · Founded 2019 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

TK
Timothy KnickerbockerExecutive Officer, Director
RD
Richard DiMarchiExecutive Officer, Director
PK
Peter Kent HawrylukExecutive Officer, Director

Investors · 1

Frazier Life SciencesreportedPalo Altovia Patrick Heron · board

Reported raises · per SEC filings

Form D private placements
▶$46.7MraisedNov 2022 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James M. CorneliusDirector
  • Patrick HeronDirector
  • Edward MathersDirector
  • Richard DiMarchiExecutive Officer, Director
  • Tiba AynechiDirector
  • Peter Kent HawrylukExecutive Officer, Director
  • Ora PescovitzDirector
  • Carl GordonDirector
  • Richard BartramExecutive Officer
Offering amount
$115.2M
Amount sold
$46.7M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.8MraisedJul 2020 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy KnickerbockerExecutive Officer, Director
  • Richard DiMarchiExecutive Officer, Director
  • Peter Kent HawrylukExecutive Officer, Director
Offering amount
$35.8M
Amount sold
$25.8M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedMay 2019 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard DiMarchiExecutive Officer, Director
  • Timothy KnickerbockerExecutive Officer, Director
  • Peter Kent HawrylukExecutive Officer, Director
Offering amount
$5M
Amount sold
$2.3M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.